zika
viru
zikv
emerg
mosquitoborn
flaviviru
becam
global
public
concern
due
associ
increas
congenit
microcephali
case
brazil
zikv
first
isol
sentinel
rhesu
monkey
zika
forest
zikv
infect
human
first
describ
jaundic
epidem
nigeria
sporad
case
zikv
infect
human
report
africa
asia
last
zikv
caus
first
outbreak
yap
island
feder
state
micronesia
almost
popul
show
sign
zikv
histor
associ
mild
febril
ill
similar
caus
mosquitoborn
diseas
public
relev
dengu
viru
denv
yellow
fever
viru
yfv
chikungunya
viru
chikv
similar
clinic
sign
zikv
diseas
denv
chikv
interf
zikv
diagnosi
probabl
underestim
number
case
zikv
howev
zikv
becom
major
human
health
concern
due
associ
sever
neurolog
complic
includ
increas
risk
syndrom
adult
larg
outbreak
french
polynesia
dramat
increas
sever
congenit
malform
includ
fetal
microcephali
neonat
massiv
epidem
emerg
brazil
sinc
million
infect
individu
report
south
central
america
caribbean
south
unit
zikv
primarili
transmit
bite
infect
aed
spp
mosquito
aed
aegypti
aed
albopictu
howev
nonvector
zikv
transmiss
report
occur
vertic
transmiss
mother
sexual
addit
zikv
rna
detect
bodi
fluid
includ
blood
urin
semen
saliva
breast
milk
increas
risk
human
human
transmiss
via
direct
contact
bodi
fluid
infect
zikv
posit
singlestrand
rna
viru
genom
kb
contain
cap
structur
singl
open
read
frame
orf
flank
two
untransl
region
utr
orf
encod
singl
polyprotein
approxim
amino
acid
co
posttransl
process
viral
cellular
proteas
produc
three
structur
protein
capsid
c
premembran
prm
envelop
e
seven
nonstructur
ns
protein
phylogenet
analys
zikv
genom
identifi
two
major
genet
lineag
african
zikv
strain
recent
epidem
america
phylogenet
relat
asian
molecular
determin
zikv
evolut
spread
virul
diseas
total
establish
postul
zikv
genom
chang
may
evolv
modifi
tissu
tropism
becom
andor
effici
transmit
virul
factor
associ
zikv
pathogenesi
remain
unknown
last
year
extens
effort
made
develop
vitro
vivo
approach
studi
zikv
infect
pathogenesi
includ
revers
genet
suitabl
anim
model
sens
emerg
zikv
promot
rapid
develop
numer
revers
genet
constitut
essenti
tool
research
gener
recombin
virus
contain
specif
substitut
evalu
contribut
viral
replic
transcript
pathogen
virushost
interact
viral
tropism
recent
develop
revers
genet
approach
base
use
bacteri
artifici
chromosom
bac
assembl
fulllength
cdna
viral
genom
zikv
rio
grand
nort
natal
rgn
strain
brazil
hand
anim
model
essenti
understand
biolog
pathogenesi
zikv
known
infect
immunocompet
mice
result
littl
viru
product
infect
mice
develop
howev
mice
defici
interferon
ifn
signal
pathway
display
enhanc
suscept
infect
zikv
flavivirus
recapitul
mani
symptom
associ
infect
therefor
anim
model
current
use
studi
zikv
infect
vivo
includ
develop
new
therapeut
approach
combat
andor
prevent
zikv
present
studi
analyz
virul
zikvrgn
paraiba
two
viral
strain
identifi
recent
outbreak
brazil
use
valid
typei
ifn
receptor
defici
mice
model
zikv
infect
observ
zikvparaiba
virul
replic
higher
level
compar
rzikvrgn
combin
deepsequenc
analysi
revers
genet
system
identifi
singl
amino
acid
polymorph
posit
viral
protein
respons
differ
virul
zikv
strain
polymorph
zikv
affect
host
innat
immun
respons
viralinduc
apoptosi
therefor
repres
import
viral
genet
marker
riskassess
prevent
futur
zikv
outbreak
recent
gener
infecti
cdna
clone
zikvrgn
pbaczikvrgn
use
bac
infecti
recombin
r
zikvrgn
success
recov
transfect
vero
genom
sequenc
zikvrgn
obtain
infect
fetu
microcephali
recent
outbreak
brazil
interestingli
compar
rzikvrgn
contemporari
zikvparaiba
strain
isol
febril
femal
state
paraiba
brazil
observ
signific
differ
vitro
vivo
fig
strain
analysi
growth
kinet
revel
virus
replic
effici
vero
cell
fig
reach
titer
approxim
focusform
unit
per
ml
ffuml
hour
postinfect
hpi
howev
earli
time
postinfect
hpi
rzikvrgn
signific
delay
replic
kinet
compar
zikvparaiba
addit
analysi
plaqu
phenotyp
immunostain
show
day
infect
rzikvrgn
produc
smaller
plaqu
zikvparaiba
fig
assess
pathogen
vivo
rzikvrgn
zikvparaiba
group
sixtosevenweekold
femal
mice
n
inocul
subcutan
sc
footpad
differ
dose
ffumous
zikvparaiba
rzikvrgn
monitor
daili
sign
morbid
bodi
weight
loss
clinic
diseas
sign
surviv
day
fig
notabl
mice
infect
zikvparaiba
suffer
rapid
dosedepend
weight
loss
day
fig
upper
panel
show
clear
neurolog
diseas
sign
includ
tremor
disorient
hind
limb
weak
sever
paralysi
fig
middl
panel
anim
die
euthan
day
postinfect
fig
lower
panel
surprisingli
ffu
zikvparaiba
suffici
result
mortal
mous
lethal
dose
ffu
contrast
previous
mice
infect
high
dose
ffu
rzikvrgn
lost
weight
succumb
viral
infect
result
calcul
ffu
fig
right
panel
remark
mice
succumb
rzikvrgn
infect
present
similar
diseas
symptom
observ
zikvparaiba
case
mice
infect
ffu
rzikvrgn
anim
present
sign
ill
hunch
postur
reduc
movement
lost
weight
day
recov
initi
bodi
weight
surviv
viral
infect
fig
right
panel
mice
infect
ffu
rzikvrgn
present
clinic
symptom
surviv
viral
infect
agreement
observ
mice
infect
zikvparaiba
signific
higher
viremia
mice
infect
rzikvrgn
day
infect
fig
correl
differ
observ
morbid
mortal
fig
abil
virus
replic
vivo
fig
identifi
virul
factor
respons
dramat
differ
virul
rzikvrgn
zikvparaiba
first
sequenc
laboratori
stock
zikvparaiba
univers
rochest
ur
deepsequenc
tabl
although
complet
sequenc
zikvparaiba
previous
deposit
genbank
know
passag
histori
zikvparaiba
sever
nucleotid
differ
laboratori
refer
zikvparaiba
sequenc
identifi
tabl
interestingli
differ
correspond
genet
variant
quasispeci
suggest
zikvparaiba
popul
differ
genom
previous
describ
base
sequenc
result
consensu
sequenc
zikvparaiba
determin
consid
frequent
nucleotid
variant
frequenc
tabl
grey
base
consensu
sequenc
six
nonsynonym
nucleotid
substitut
zikvparaiba
refer
sequenc
identifi
result
amino
acid
chang
prm
protein
one
protein
two
protein
tabl
grey
genet
ident
rzikvrgn
previous
determin
show
ident
publish
zikvrgn
sequenc
genbank
access
number
compar
sequenc
analysi
rzikvrgn
zikvparaiba
ur
show
nucleotid
differ
virus
result
amino
acid
substitut
local
prm
protein
tabl
one
nucleotid
substitut
present
utr
base
data
hypothes
amino
acid
differ
identifi
viral
polyprotein
nucleotid
chang
utr
combin
could
respons
differ
virul
viral
replic
observ
vivo
rgn
paraiba
strain
identifi
virul
factor
associ
zikvparaiba
first
gener
infecti
cdna
clone
zikvparaiba
pbaczikvparaiba
use
revers
genet
approach
previous
describ
gener
fig
end
use
site
direct
mutagenesi
introduc
nonsynonym
substitut
fig
black
arrow
except
protein
present
zikvparaiba
previous
describ
likewis
chang
utr
also
introduc
fig
blue
arrow
introduc
amino
acid
substitut
pbaczikvparaiba
infecti
clone
substitut
caus
conserv
amino
acid
chang
v
approxim
zikvparaiba
tabl
addit
analysi
publicli
avail
zikv
sequenc
show
zikv
strain
contain
alanin
amino
acid
residu
posit
protein
http
wwwviprbrcorgbrchomespg
decor
flavizika
rzikvparaiba
success
recov
transfect
pbaczikvparaiba
vero
cell
growth
kinet
vero
cell
natur
zikvparaiba
isol
rzikvparaiba
compar
found
virus
replic
effici
fig
similar
plaqu
phenotyp
fig
nonetheless
seen
viral
titer
slightli
reduc
compar
natur
zikv
isol
later
time
point
fig
due
loss
viral
quasispeci
divers
wide
importantli
plaqu
size
rzikvparaiba
similar
natur
zikvparaiba
fig
suggest
nine
amino
acid
substitut
chang
utr
introduc
infecti
rzikvrgn
clone
gener
rzikvparaiba
result
increas
viral
replic
plaqu
phenotyp
cultur
cell
taken
togeth
result
demonstr
abl
rescu
rzikvparaiba
similar
vitro
characterist
natur
viral
isol
determin
whether
rescu
rzikvparaiba
pathogen
vivo
group
sixtosevenweekold
femal
mice
n
inocul
sc
footpad
differ
dose
ffumous
rzikvparaiba
natur
zikvparaiba
isol
monitor
daili
morbid
bodi
weight
loss
clinic
diseas
sign
mortal
day
fig
previous
show
mice
infect
ffu
natur
zikvparaiba
began
lose
weight
day
postinfect
succumb
viral
infect
day
postinfect
fig
right
panel
contrast
rzikvparaiba
highli
attenu
compar
natur
zikvparaiba
isol
fig
left
panel
mice
infect
ffu
rzikvparaiba
show
sign
diseas
case
anim
infect
ffu
rzikvparaiba
one
mous
present
slightli
weight
loss
surviv
viral
infect
mice
infect
ffu
rzikvparaiba
present
evid
sign
infect
mice
show
weight
loss
day
postinfect
one
succumb
viral
infect
day
postinfect
ffu
fig
left
panel
analyz
rzikvparaiba
viremia
group
sixtosevenweekold
femal
mice
n
infect
differ
dose
ffumous
rzikvparaiba
natur
zikvparaiba
isol
viral
titer
mous
sera
analyz
day
postinfect
fig
viral
titer
zikvparaiba
mice
sera
significantli
higher
rzikvparaiba
dose
time
analyz
fig
altogeth
data
indic
although
amino
acid
substitut
singl
nucleotid
chang
utr
introduc
rzikvrgn
infecti
clone
gener
rzikvparaiba
increas
viral
replic
vitro
fig
vivo
fig
compar
rzikvrgn
rzikvparaiba
attenu
vivo
show
compar
virul
rzikvrgn
demonstr
mutat
respons
phenotyp
differ
natur
isol
zikvparaiba
rzikvrgn
deepsequenc
analysi
zikvparaiba
identifi
sever
genet
variant
laboratori
zikvparaiba
stock
tabl
could
respons
differ
observ
virul
zikvparaiba
rzikvrgn
fig
importantli
miner
et
al
describ
increas
frequenc
c
substitut
posit
eye
spleen
brain
deriv
virus
zikvparaiba
infect
note
singl
nucleotid
substitut
c
result
conserv
amino
acid
substitut
zikv
protein
amino
acid
chang
identifi
initi
deep
sequenc
analysi
tabl
includ
construct
infecti
rzikvparaiba
clone
fig
explor
possibl
substitut
respons
differ
virul
natur
recombin
zikvparaiba
infecti
clone
rzikvparaiba
contain
addit
chang
pbaczikvparaiba
gener
sitedirect
mutagenesi
fig
rzikvparaiba
success
recoveri
vero
cell
replic
vitro
compar
rzikvparaiba
fig
c
importantli
rzikvparaiba
grew
similarli
rzikvparaiba
vero
cell
statist
differ
viral
growth
kinet
time
point
analyz
fig
moreov
rzikvparaiba
rzikvparaiba
produc
plaqu
similar
size
day
infect
fig
investig
whether
rzikvparaiba
virul
vivo
group
sixtosevenweekold
femal
mice
n
inocul
sc
footpad
differ
dose
ffumous
rzikvparaiba
rzikvparaiba
fig
mice
monitor
daili
day
sign
morbid
bodi
weight
loss
clinic
diseas
sign
mortal
fig
interestingli
similar
mice
infect
zikvparaiba
fig
mice
infect
rzikvparaiba
rapidli
lost
weight
dosedepend
manner
show
strong
sign
infect
necessit
euthanasia
day
postinfect
calcul
ffu
fig
left
panel
contrast
previous
shown
fig
rzikvparaiba
highli
attenu
mice
surviv
ffu
infecti
dose
succumb
viral
infect
ffu
ffu
fig
right
panel
demonstr
virul
correl
viral
replic
sixtosevenweekold
femal
mice
infect
ffu
rzikvparaiba
rzikvparaiba
fig
agreement
morbid
mortal
result
mice
infect
rzikvparaiba
fig
left
panel
present
statist
higher
viremia
mice
infect
rzikvparaiba
day
postinfect
fig
right
panel
compar
replic
natur
zikvparaiba
isol
fig
left
panel
fig
right
panel
howev
mice
infect
ffu
rzikvparaiba
fig
right
panel
produc
high
viremia
day
postinfect
reach
titer
approxim
ffuml
similar
obtain
rzikvparaiba
fig
left
panel
zikvparaiba
infect
fig
altogeth
data
support
singl
amino
acid
substitut
zikv
protein
respons
differ
virul
zikvparaiba
natur
isol
rzikvrgn
fig
deepsequenc
analysi
result
indic
zikvparaiba
exist
popul
differ
genom
quasispeci
tabl
determin
whether
presenc
zikv
respons
virul
isol
individu
clone
zikvparaiba
plaqu
purif
vero
cell
fig
plaqu
assay
result
show
individu
isol
zikvparaiba
clone
similar
plaqu
phenotyp
vero
cell
fig
howev
sequenc
analysi
determin
clone
c
clone
posit
fig
correl
proport
previous
determin
deepsequenc
natur
isol
zikvparaiba
c
tabl
determin
virul
plaquepurifi
zikvparaiba
clone
vivo
group
sixtosevenweekold
femal
mice
n
infect
sc
footpad
ffumic
individu
isol
clone
monitor
bodi
weight
loss
surviv
fig
day
intern
control
studi
mice
infect
ffu
zikvparaiba
interestingli
zikvparaiba
plaquepurifi
clone
contain
clone
pathogen
mice
show
strong
sign
neurolog
diseas
hind
limb
paralysi
data
shown
anim
die
euthan
day
postinfect
fig
contrast
mice
inocul
zikvparaiba
plaquepurifi
clone
contain
surviv
viral
infect
without
diseas
sign
data
shown
bodi
weight
lost
fig
demonstr
zikv
respons
least
part
vivo
pathogen
natur
zikvparaiba
next
evalu
whether
singl
substitut
could
suffici
increas
virul
rzikvrgn
end
gener
infecti
clone
contain
substitut
c
posit
rzikvrgn
genom
pbaczikvrgn
fig
rescu
recombin
viru
vero
cell
compar
vitro
phenotyp
rzikvrgn
rzikvrgn
fig
b
rzikvrgn
grew
similarli
rzikvrgn
show
statist
differ
viral
titer
time
point
analyz
fig
likewis
plaqu
phenotyp
similar
rzikvrgn
rzikvrgn
fig
indic
singl
amino
acid
substitut
protein
effect
viral
replic
vitro
next
assess
contribut
virul
replic
vivo
fig
group
sixtosevenweekold
femal
mice
n
inocul
sc
footpad
differ
dose
ffumous
rzikvrgn
rzikvrgn
anim
monitor
bodi
weight
loss
fig
upper
panel
clinic
sign
fig
middl
panel
surviv
fig
lower
panel
day
mice
infect
rzikvrgn
rapidli
lost
weight
succumb
viral
infect
day
postinfect
fig
left
panel
notabl
mice
infect
ffu
rzikvrgn
show
clear
sign
infect
lost
weight
rapidli
die
day
postinfect
fig
left
panel
remain
two
mice
display
weight
loss
lethargi
although
surviv
viral
infect
fig
left
panel
base
data
determin
rzikvrgn
ffu
expect
mice
infect
ffumous
rzikvrgn
reduc
morbid
sing
recov
surviv
viral
infect
fig
right
panel
remark
singl
substitut
zikv
result
mark
increas
virul
log
differ
rzikvrgn
ffu
fig
rzikvrgn
ffu
fig
notabl
pathogenesi
observ
rzikvrgn
resembl
observ
natur
zikvparaiba
isol
fig
addit
evalu
whether
virul
observ
vivo
correl
viral
replic
group
sixtosevenweekold
femal
mice
n
inocul
ffu
rzikvrgn
rzikvrgn
viremia
determin
day
postinfect
fig
rzikvrgn
replic
higher
titer
rzikvrgn
differ
log
day
postinfect
respect
altogeth
result
demonstr
substitut
zikv
contribut
significantli
viral
pathogenesi
viremia
repres
new
import
zikv
virul
factor
flaviviru
protein
membraneassoci
protein
involv
modul
host
innat
immun
determin
whether
substitut
zikv
protein
immunomodulatori
role
innat
immun
respons
analyz
cell
infect
rzikv
paraiba
rgn
carri
protein
fig
vero
cell
use
analyz
growth
kinet
rzikv
fig
known
defici
ifn
reason
cell
innat
immun
compet
cell
line
deriv
human
lung
adenocarcinoma
chosen
assess
innat
immun
respons
furthermor
cell
previous
report
support
effici
replic
zikv
lead
product
ifn
ifn
stimul
gene
isg
proinflammatori
firstli
evalu
whether
rzikvparaiba
rzikvparaiba
rzikvrgn
rzikvrgn
could
infect
grow
effici
cell
fig
data
indic
virus
abl
replic
cell
polymorph
significantli
affect
least
earli
time
postinfect
product
infecti
viru
cell
infect
moi
rzikv
fig
express
level
sever
isg
includ
myxoviru
resist
protein
ifninduc
protein
tetratricopeptid
repeat
dexdbox
helicas
human
tumor
necrosi
factor
alpha
evalu
quantit
rtpcr
rtqpcr
hpi
fig
agreement
previou
data
zikv
infect
result
induct
isg
fig
howev
significantli
decreas
mrna
express
level
gene
observ
cell
infect
rzikvparaiba
rzikvrgn
contain
rzikvparaiba
rzikvrgn
compar
virus
contain
rzikvparaiba
rzikvrgn
fig
result
suggest
amino
acid
substitut
zikv
modul
antivir
respons
neg
regul
express
innat
immun
gene
systemat
observ
increas
induct
cytopath
effect
cpe
infect
rzikvparaiba
rzikvrgn
compar
rzikvparaiba
rzikvrgn
data
shown
addit
previou
studi
shown
zikv
infect
trigger
apoptot
cell
death
human
neuron
epitheli
cell
confirm
observ
evalu
whether
amino
acid
substitut
zikv
involv
regul
apoptosi
viral
infect
measur
caspas
activ
fig
end
cell
mock
infect
infect
moi
rzikvparaiba
rzikvparaiba
rzikvrgn
rzikvrgn
caspas
activ
analyz
hpi
expect
zikv
infect
result
activ
caspas
activ
start
hpi
fig
importantli
observ
signific
increas
caspas
activ
infect
rzikvparaiba
rzikvrgn
compar
rzikvparaiba
rzikvrgn
respect
earli
time
postinfect
fig
howev
differ
signific
hpi
even
hpi
rzivkrgn
fig
result
suggest
substitut
zikv
prevent
delay
induct
apoptosi
correl
differ
observ
level
induct
fig
altogeth
data
indic
tissu
cultur
cell
zikv
modul
antivir
respons
delay
induct
apoptosi
viral
infect
determin
viral
factor
associ
zikv
diseas
critic
understand
combat
zikv
infect
well
predict
futur
potenti
viral
outbreak
studi
compar
virul
two
close
relat
zikv
strain
rgn
paraiba
recent
outbreak
brazil
despit
virus
identifi
time
period
region
signific
differ
viral
replic
virul
observ
vitro
vivo
use
valid
mous
model
zikv
infect
fig
mice
infect
ffu
zikvparaiba
show
clear
diseas
sign
dramat
weight
loss
succumb
viral
infect
calcul
ffu
contrast
mice
infect
ffu
rzikvrgn
show
clear
sign
infect
loss
signific
bodi
weight
succumb
viral
infect
calcul
ffu
fig
genom
sequenc
analysi
virus
show
presenc
amino
acid
chang
code
region
prm
one
nucleotid
substitut
utr
tabl
first
approach
introduc
substitut
except
previous
describ
rzikvrgn
infecti
gener
rzikvparaiba
fig
notabl
although
chang
improv
viral
replic
vitro
signific
effect
viral
pathogenesi
vivo
fig
surprisingli
found
singl
amino
acid
chang
suffici
recapitul
vivo
pathogen
phenotyp
zikvparaiba
presenc
fig
absenc
fig
remain
amino
acid
chang
identifi
genom
sequenc
analysi
interestingli
vitro
growth
kinet
plaqu
phenotyp
characterist
rzikvparaiba
least
part
attribut
effect
amino
acid
substitut
code
region
prm
andor
nucleotid
substitut
fig
individu
contribut
chang
well
synonym
chang
zikvparaiba
rzikvrgn
identifi
sequenc
analysi
tabl
directli
address
studi
could
also
play
import
role
viral
replic
andor
virul
urgent
need
compar
analysi
zikv
strain
identifi
virul
factor
associ
viral
pathogenesi
date
limit
number
studi
perform
compar
diseas
caus
differ
zikv
isol
suggest
lineagespecif
differ
involv
viral
interestingli
yuan
et
al
provid
experiment
evid
singl
amino
acid
substitut
zikv
prm
acquir
prior
outbreak
french
polynesia
contribut
increas
neurovirul
contemporari
zikv
addit
liu
et
al
demonstr
singl
amino
acid
chang
zikv
protein
promot
acquisit
zikv
aed
mosquito
infect
host
therefor
viru
preval
interestingli
two
amino
acid
chang
prm
present
viral
strain
use
studi
suggest
addit
two
evolutionari
adapt
specif
genom
differ
polymorph
contribut
zikv
pathogenesi
could
explain
recent
outbreak
zikv
polymorph
identifi
zikv
sequenc
deposit
public
databas
one
isol
patient
cutan
rash
pain
fever
outbreak
brazil
remain
zikv
isol
aed
aegypti
mosquito
includ
viru
malaysia
mexico
nonetheless
previous
describ
zikv
observ
popul
genet
variant
quasispeci
zikvparaiba
stock
tabl
substitut
detect
frequenc
zikvparaiba
stock
tabl
howev
previou
studi
show
substitut
present
frequenc
zikvparaiba
stock
notabl
detect
frequenc
clinic
strain
isol
french
polynesia
suggest
mutat
could
present
zikv
strain
low
frequenc
importantli
plaqu
purif
studi
fig
abl
isol
individu
zikvparaiba
clone
demonstr
respons
virul
zikvparaiba
vivo
fig
studi
support
gener
rzikvparaiba
fig
rzikvrgn
contain
fig
surprisingli
rzikvrgn
isol
infect
fetu
microcephali
brazil
fulllength
sequenc
identifi
alanin
posit
viral
possibl
similar
zikvparaiba
low
percentag
zikvrgn
present
would
allow
identif
viral
quasispeci
sequenc
process
majoritarian
sequenc
usual
annot
worth
note
zikvrgn
isol
microcephali
make
difficult
evalu
possibl
andor
futur
studi
flaviviru
protein
multifunct
membraneassoci
protein
involv
viral
rna
viru
immunomodul
innat
immun
flaviviru
infect
date
role
zikv
viral
infect
pathogenesi
well
understood
although
homolog
rest
flavivirus
zikv
could
similar
function
recent
zikv
denv
involv
disrupt
mammalian
cortic
neurogenesi
degrad
adher
junction
also
previous
identifi
alaninetovalin
substitut
residu
zikv
import
viral
rna
synthesi
pathogenesi
studi
demonstr
singl
amino
acid
substitut
zikv
signific
impact
viral
pathogenesi
replic
vivo
although
analyz
presenc
zikv
sera
three
infect
mice
futur
exhaust
studi
requir
determin
substitut
affect
viral
replic
organ
andor
tissu
zikv
shown
replic
brain
placenta
andor
likewis
major
effort
evalu
role
zikv
viral
replic
virul
clearli
need
ifn
respons
induc
potent
antivir
state
elicit
upregul
hundr
isg
confer
protect
infect
cell
neighbor
noninfect
cell
howev
virus
develop
sophist
strategi
inhibit
delay
ifn
respons
andor
antivir
activ
isg
includ
result
show
virul
rzikv
carri
protein
induc
significantli
less
isg
compar
attenu
rzikv
contain
also
delay
induct
cpe
observ
rzikvrgn
rzikvparaiba
contain
chang
correl
delay
induct
apoptosi
infect
cell
fig
notabl
similar
studi
earli
induct
apoptosi
gener
associ
viral
attenu
sinc
apoptosi
power
antivir
host
mechan
limit
viral
replic
trigger
ifn
could
repres
least
part
mechan
underli
increas
pathogenesi
observ
natur
zikvparaiba
rzikv
rgn
paraiba
contain
substitut
worth
note
although
use
typei
ifn
receptor
defici
mice
studi
mice
retain
intact
typeii
ifn
involv
induct
innat
immun
respons
apoptosi
multipl
cell
line
may
contribut
control
viral
replic
fact
sever
studi
use
mice
describ
role
viral
report
contribut
control
viral
replic
spread
summari
identifi
singl
amino
acid
chang
zikv
dramat
increas
virul
vivo
well
amino
acid
chang
zikv
open
possibl
target
zikv
ration
design
life
attenu
vaccin
prophylact
treatment
zikv
infect
likewis
studi
also
open
feasibl
target
zikv
protein
small
molecul
compound
therapeut
treatment
zikv
infect
vero
african
green
monkey
kidney
epitheli
atcc
human
atcc
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
unitsml
penicillin
streptomycin
psg
zikv
strain
paraiba
brazil
kindli
provid
dr
stephen
dewhurst
depart
microbiolog
immunolog
univers
rochest
medic
center
rzikvrgn
previous
viru
stock
propag
vero
cell
titrat
plaqu
assay
previous
viral
rna
isol
purifi
virion
use
qiaamp
viral
rna
minikit
quiagen
deepsequenc
conduct
univers
rochest
genom
research
center
use
illumina
miseq
illumina
san
diego
ca
usa
previous
infecti
cdna
clone
pbaczikvparaiba
pbaczikvparaiba
pbaczikvrgn
gener
use
previous
describ
pbaczikvrgn
infecti
cdna
gener
pbaczikvparaiba
nonsil
mutat
viral
code
region
prm
singl
nucleotid
substitut
utr
tabl
introduc
sitedirect
mutagenesi
intermedi
plasmid
contain
zikv
fragment
modifi
cdna
fragment
replac
pbaczikvrgn
use
select
restrict
addit
silent
nucleotid
mutat
introduc
order
gener
bsrb
posit
g
sap
posit
g
c
g
restrict
site
genet
marker
gener
pbaczikvparaiba
pbaczikvrgn
singl
amino
acid
chang
introduc
pbaczikvparaiba
pbaczikvrgn
respect
plasmid
construct
confirm
sequenc
acgt
inc
propag
e
coli
gibcobrl
prepar
use
qiagen
largeconstruct
kit
qiagen
inc
follow
manufactur
specif
primer
sequenc
construct
differ
plasmid
avail
request
infecti
virus
recov
bac
cdna
clone
previous
briefli
subconflu
monolay
vero
cell
plate
format
cellswel
transient
transfect
bac
cdna
clone
use
lipofectamin
invitrogen
h
transfect
media
remov
replac
fresh
viral
growth
medium
dmem
supplement
fb
psg
cell
incub
cpe
evid
day
tissu
cultur
supernat
collect
store
ident
recov
virus
confirm
sequenc
acgt
inc
specif
primer
briefli
viral
rna
purifi
use
rneasi
minikit
qiagen
inc
infect
vero
cell
revers
transcript
rt
perform
use
highcapac
cdna
transcript
kit
thermofish
scientif
purifi
rna
random
hexam
primer
cdna
amplifi
use
expand
high
fidel
pcr
kit
roch
sequenc
use
specif
primer
avail
request
viral
titer
determin
immunofocu
assay
briefli
subconflu
monolay
vero
cell
plate
format
cellswel
triplic
infect
serial
dilut
viruscontain
tissu
cultur
supernat
sampl
min
viral
absorpt
viru
inoculum
remov
cell
monolay
overlaid
viral
growth
media
contain
microcrystallin
cellulos
avicel
sigmaaldrich
hpi
cell
fix
formaldehyd
h
room
temperatur
overlay
remov
cell
permeabil
triton
pb
min
room
temperatur
block
bovin
serum
albumin
bsa
pb
use
immunofluoresc
panflaviviru
e
protein
monoclon
antibodi
mab
bei
resourc
secondari
goat
antimous
igg
invitrogen
viral
titer
express
ffuml
determin
averag
number
eposit
foci
highest
dilut
triplic
subconflu
monolay
vero
cell
plate
format
cellswel
infect
ml
virus
min
ml
viral
growth
media
supplement
agar
nobl
difco
deaedextran
sigmaaldrich
ad
well
day
incub
cell
fix
formaldehyd
h
overlay
remov
cell
permeabil
triton
pb
min
room
temperatur
prepar
immunostain
use
panflaviviru
e
protein
mab
viral
plaqu
visual
use
vectastin
abc
kit
dab
hrp
substrat
vector
laboratori
inc
follow
manufactur
instruct
plaqu
assay
zikvparaiba
perform
describ
six
repres
viral
plaqu
isol
grown
vero
cell
cpe
evid
day
postinfect
tissu
cultur
supernat
collect
store
viral
titer
determin
immunofocu
assay
vero
cell
describ
presenc
protein
confirm
sequenc
acgt
inc
subconflu
monolay
vero
cell
plate
format
cellswel
triplic
infect
moi
indic
virus
min
viru
absorpt
viru
inoculum
remov
infect
cell
overlaid
ml
fresh
viral
growth
media
incub
indic
time
postinfect
aliquot
tissu
cultur
supernat
collect
viral
titer
determin
immunofocu
assay
vero
cell
describ
mean
valu
sd
calcul
use
microsoft
excel
softwar
mice
jackson
laboratori
bred
maintain
anim
care
facil
univers
rochest
specif
pathogenfre
condit
anim
protocol
approv
univers
rochest
committe
anim
resourc
compli
recommend
guid
care
use
laboratori
anim
nation
research
sixtosevenweekold
femal
mice
n
anesthet
intraperiton
mixtur
ketamin
per
gram
bodi
weight
xylazin
per
gram
bodi
weight
infect
sc
footpad
indic
dose
zikvparaiba
rzikvparaiba
rzikvparaiba
rzikvrgn
rzikvrgn
dilut
pb
final
volum
mice
monitor
daili
clinic
sign
zikv
infect
lethargi
disorient
hind
limb
weak
sever
paralysi
bodi
weight
loss
mortal
day
clinic
sign
score
follow
healthi
lightli
sick
hunch
back
lethargi
disorient
reduc
mobil
hind
limb
weak
sever
paralysi
mortal
mice
show
loss
initi
bodi
weight
present
sever
hind
limb
paralysi
consid
reach
experiment
endpoint
human
euthan
correl
sing
diseas
viru
replic
sixtosevenweekold
femal
n
infect
describ
bled
day
n
n
viral
infect
blood
incub
room
temperatur
min
clarifi
centrifug
g
min
supernat
immedi
store
viral
titer
serum
determin
immunofocu
assay
previous
describ
graphpad
prism
softwar
use
determin
geometr
mean
titer
reed
muench
method
determin
cellular
gene
express
vrna
synthesi
evalu
rtqpcr
total
intracellular
rna
mockinfect
infect
moi
cell
rzikvparaiba
rzikvparaiba
rzikvrgn
rzikvrgn
purifi
hpi
use
rneasi
minikit
qiagen
inc
follow
manufactur
specif
total
cdna
synthes
ng
purifi
rna
use
random
hexam
primer
highcapac
cdna
transcript
kit
appli
biosystem
thermofish
scientif
amplifi
cdna
use
evalu
cellular
gene
express
use
specif
taqman
assay
appli
biosystem
thermofish
scientif
quantifi
level
vrna
custom
taqman
assay
specif
zikv
rna
case
histon
taqman
assay
appli
biosystem
thermofish
scientif
use
refer
housekeep
gene
normal
differ
rna
sampl
data
acquir
qpcr
system
appli
biosystem
thermofish
scientif
analyz
abi
prism
softwar
quantif
done
use
cycl
threshold
quantif
caspas
activ
perform
use
caspas
glo
assay
kit
promega
follow
manufactur
specif
briefli
subconflu
monolay
cell
plate
format
cellswel
triplic
mockinfect
infect
moi
indic
virus
h
viru
absorpt
viral
inoculum
remov
ml
fresh
viral
growth
media
ad
indic
time
postinfect
cell
harvest
tissu
cultur
supernat
frozen
analysi
cell
lysat
incub
caspaseglo
substrat
plate
dark
h
room
temperatur
luciferas
activ
determin
use
lumicount
luminomet
quantit
analys
twotail
unpair
student
test
use
analyz
differ
mean
valu
group
result
express
mean
standard
deviat
sd
mean
p
valu
consid
signific
